Join the club for FREE to access the whole archive and other member benefits.

Johann de Bono

Consultant at the Institute of Cancer Research

Professor Johann de Bono is Head of the Division of Clinical Studies and an international expert in the development of molecularly targeted cancer therapies against adult cancers. He runs one of the world’s largest phase I clinical trials units for cancer and has also led phase III trials of the prostate cancer drugs abiraterone and cabazitaxel.

Visit website: https://www.icr.ac.uk/our-research/researchers-and-teams/professor-johann-de-bono

 johann-de-bono-a826a816

See also: Institute The Institute of Cancer Research (ICR) - One of the world’s most influential cancer research organizations

Details last updated 25-Oct-2019

Johann de Bono News

New missile-like radioactive therapy treats prostate cancer

The Institute of Cancer Research (ICR) - 03-Jun-2021

Precisely targeted therapy shrank tumours and extends life by 38% in men

Read more...

An effective immunotherapy for advanced prostate cancer

BBC - 28-Nov-2019

Only 5% saw their tumours shrink, but may be more successful if used earlier

Read more...

New drug slowed tumour growth in men with prostate cancer

BBC - 30-Sep-2019

Olaparib delays cancer growth by months, which means the increased lifespan

Read more...

Drug attacks cancers cells using trojan horse antibody

Independent - 08-Feb-2019

Novel mechanisms for attacking cancer cells are always good news

Read more...

Prostate cancer treatment with a genetic test

The Institute of Cancer Research (ICR) - 10-Oct-2017

Genetic test is a faster, less expensive treatment method for men with advanced prostate cancer

Read more...

Nine out of ten male prostate cancer sufferers could be treated

Independent - 21-May-2015

Study finds prostate cancer is not one disease but several – enabling personalised treatments usi...

Read more...